08/13/2025
10:27 AM | Acumen Pharmaceuticals (Subject)
Sands Capital Alternatives, LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/12/2025
7:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2025
6:30 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
5:05 PM | Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
5:12 PM | Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:51 PM | Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:52 PM | Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:57 PM | Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:57 PM | Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:59 PM | Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
3:36 PM | Acumen Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
05/13/2025
6:32 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
3:57 PM | Acumen Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/27/2025
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2025
3:38 PM | Acumen Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2025
6:24 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2025
8:19 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:14 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:16 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:18 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:06 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:17 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:31 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:32 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:24 PM | Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
3:25 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
6:57 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:00 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:02 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:09 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:48 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:53 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
6:55 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:16 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
4:54 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
4:59 PM | Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
5:04 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:24 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
4:27 PM | Acumen Pharmaceuticals (Issuer)
Schacterle Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
